These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 1514832

  • 1. Allogeneic bone marrow transplantation for the patients with hemopoietic stem cell disorders: CUMC experience.
    Kim DJ, Kim CC, Park CW, Han CH, Kim HK, Kim WI, Han KJ, Choi IB.
    Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1188-92. PubMed ID: 1514832
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic bone marrow transplantation in Korea: 1983-92.
    Kim DJ, Kim CC, Kim BK, Kim DW, Lee JW, Jin JY, Han CW, Min WS, Park CW, Kim HK.
    Bone Marrow Transplant; 1994 Jun; 13(6):717-9. PubMed ID: 7920301
    [Abstract] [Full Text] [Related]

  • 3. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J.
    Bone Marrow Transplant; 1993 Jun; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [Abstract] [Full Text] [Related]

  • 4. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 5. [Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors].
    Nachbaur D, Schwaighofer H, Thaler J, Weyrer W, Fink M, Nussbaumer W, Fritsch E, Niederwieser D.
    Wien Klin Wochenschr; 1994 Jul; 106(7):201-7. PubMed ID: 8197754
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL, Barnett MJ, Brain MC, Chan KW, Huebsch LB, Klingemann HG, Meharchand J, Reece DE, Rybka WB, Shepherd JD.
    Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
    [Abstract] [Full Text] [Related]

  • 7. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 8. [Bone marrow transplantation in leukemia and aplastic anemia].
    Speck B, Gratwohl A, Nissen C, Osterwalder B, Signer E, Jeannet M.
    Schweiz Med Wochenschr; 1983 Apr 30; 113(17):622-9. PubMed ID: 6346483
    [Abstract] [Full Text] [Related]

  • 9. [Allogeneic peripheral blood stem cell transplantation for high-risk leukemia].
    Huang X, Wang F, Guo N.
    Zhonghua Yi Xue Za Zhi; 2001 Nov 25; 81(22):1348-51. PubMed ID: 11930625
    [Abstract] [Full Text] [Related]

  • 10. Bone marrow transplantation in severe aplastic anemia and acute or chronic leukemia.
    Schaefer UW, Mahmoud HK, Beelen DW, Hoffmann W, Becher R, Schmidt CG, Bamberg M, Quast U, Haralambie E, Linzenmeier G.
    Strahlenther Onkol; 1986 Apr 25; 162(4):214-7. PubMed ID: 3518096
    [Abstract] [Full Text] [Related]

  • 11. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
    Lee SH, Lee MH, Lee JH, Min YH, Lee KH, Cheong JW, Lee J, Park KW, Kang JH, Kim K, Kim WS, Jung CW, Choi SJ, Lee JH, Park K.
    Biol Blood Marrow Transplant; 2005 Feb 25; 11(2):122-8. PubMed ID: 15682073
    [Abstract] [Full Text] [Related]

  • 12. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Ai Zheng; 2004 Apr 25; 23(4):426-9. PubMed ID: 15087032
    [Abstract] [Full Text] [Related]

  • 13. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
    Chim CS, Lie AK, Liang R, Au WY, Kwong YL.
    Bone Marrow Transplant; 2007 Aug 25; 40(4):339-47. PubMed ID: 17572712
    [Abstract] [Full Text] [Related]

  • 14. Effect of induced GVHD in leukemia patients relapsing after allogeneic bone marrow transplantation: single-center experience of 33 adult patients.
    Min CK, Eom KS, Lee S, Kim DW, Lee JW, Min WS, Kim CC.
    Bone Marrow Transplant; 2001 May 25; 27(9):999-1005. PubMed ID: 11436112
    [Abstract] [Full Text] [Related]

  • 15. Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
    Ayash LJ, Ratanatharathorn V, Braun T, Silver SM, Reynolds CM, Uberti JP.
    Am J Hematol; 2007 Jan 25; 82(1):6-14. PubMed ID: 16986128
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic bone marrow transplantation.
    Weiden PL.
    Crit Rev Clin Lab Sci; 1983 Jan 25; 19(3):173-86. PubMed ID: 6373140
    [Abstract] [Full Text] [Related]

  • 17. Importance of bone marrow cell dose in bone marrow transplantation.
    Paulin T.
    Clin Transplant; 1992 Feb 25; 6(1):48-54. PubMed ID: 10150090
    [Abstract] [Full Text] [Related]

  • 18. Allogeneic bone marrow transplantation: experience with 92 patients.
    Selby GB, Saez RA, Epstein RB, Slease RB, Confer DL.
    J Okla State Med Assoc; 1993 Dec 25; 86(12):599-603. PubMed ID: 8126587
    [Abstract] [Full Text] [Related]

  • 19. Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation.
    Elmaagacli AH, Beelen DW, Trenn G, Schmidt O, Nahler M, Schaefer UW.
    Bone Marrow Transplant; 1999 Apr 25; 23(8):771-7. PubMed ID: 10231138
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R.
    Exp Hematol; 1995 Dec 25; 23(14):1553-62. PubMed ID: 8542946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.